18/09/2026
Adelaide, three days, hundreds of voices from across the MND community - and some really big news ๐
We supported our client, MND Australia, in amplifying its National MND Conference. They brought together researchers, clinicians, advocates, and people living with MND from across the country to raise awareness and improve the lives of those in the MND community.
And the conference came with an important milestone: from 1 October, tofersen (Qalsodyยฎ) will be listed on the PBS for eligible Australians living with SOD1-ALS, making this treatment that can slow disease progression more accessible to those who need it.